Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE osteoporosis guidance unchanged

The National Institute for Health and Clinical Excellence (NICE) has complied with a Court of Appeal ruling and reconsidered the evidence for preventing fractures in patients with osteoporosis.

The original court ruling found the NICE had failed to fully explain its decision on a specific analysis of hip fractures from a research study carried out by the manufacturer of strontium ranelate (Protelos®). The actual recommendations were not questioned by the court. The court ruled that NICE must reconsider and reissue the guidance.

NICE has now reissued the osteoporosis - primary prevention and osteoporosis - secondary prevention including strontium ranelate. The guidelines are unchanged after the review.

Action: Clinicians should be aware that these guidelines are now published and implement any necessary changes to practice.

Share 'NICE osteoporosis guidance unchanged' on Email Share 'NICE osteoporosis guidance unchanged' on Delicious Share 'NICE osteoporosis guidance unchanged' on Digg Share 'NICE osteoporosis guidance unchanged' on Facebook Share 'NICE osteoporosis guidance unchanged' on Google+ Share 'NICE osteoporosis guidance unchanged' on reddit Share 'NICE osteoporosis guidance unchanged' on StumbleUpon Share 'NICE osteoporosis guidance unchanged' on Twitter

atomic-wealth

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 770,640 spam comments.

atomic-wealth
fond-illness
summer